Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance

作者：Morrone Kerry A; Pecker Lydia H; Rand Jacob; Davila Jennifer; Oyeku Suzette; Little Jane A; Xue Xiaonan; Manwani Deepa

来源：Blood Cells, Molecules, and Diseases, 2018, 69: 53-56.

DOI：10.1016/j.bcmd.2017.09.001

• Sickle cell disease
• Antiphospholipid antibody
• Annexin A5 resistance
• Silent infarcts

Background: Sickle cell anemia (SCA) is characterized by abnormally shaped, adhesive RBCs that interact with white blood cells and the endothelium, leading to chronic hemolysis, vasculopathy and a prothrombotic state. About 10% of subjects with a thrombotic event in the general population will have an associated antiphospholipid (aPL) antibody. One proposed mechanism for the thrombophilic nature of aPL antibodies is the disruption of the potent anticoagulant annexin A5 or Annexin A5 resistance (A5R). We designed a pilot study assessing the presence of aPL antibodies and disruption of A5R in pediatric sickle cell subjects.
Methods: 39 subjects with SCA participated in this study. A5R, DRVVT, anti-beta 2GP1, anti-beta 2GP1, anti-phosphatidylserine and anti-cardiolipin antibody assays were performed.
Results: There was a high prevalence of abnormal A5R despite a low prevalence of antiphospholipid antibodies. Multivariate logistic regression analyses showed an association with silent infarcts (p = 0.015), lower hemoglobin (p = 0.037), older age (p = 0.047) and abnormal A5R.
Conclusion: We report an association between annexin A5 resistance and presence of silent infarct, low hemoglobin, and older age in a subgroup of SCA subjects. A potential role for perturbed A5R in the pathophysiology of SCA needs to be evaluated further.

• 出版日期2018-3